Huntington’s Disease Regulatory Science Consortium Critical Path for Alpha-1 Antitrypsin Deficiency CPA-1 is a public-private partnership comprised of industry partners, academic re
Electronic Clinical Outcome Assessment Consortium The Electronic Clinical Outcome Assessment (eCOA) Consortium provides scientific leadership and best practice recommendations surr
Duchenne Regulatory Science Consortium Founded in 2015, D-RSC supports collaborative research through shared data access and advances development of drug development too
CURE Drug Repurposing Collaboratory CDRC is designed to capture real-world clinical outcome data to advance drug repurposing and inform future clinical trials for dis
Critical Path to Therapeutics for the Ataxias Founded in February 2021, CPTA is a public-private partnership that optimizes clinical trials, advances therapeutic developments a
Critical Path for Rare Neurodegenerative Diseases CP-RND was founded in September 2022 to lead collaborations that advance treatments to improve the lives of those affected by rare